Industry News
Natural selection and inflammation may hold key to age-associated cancer risk
11/12/2015
Without age-associated inflammation, older mice developed leukemia no faster than young mice.The incidence of cancer increases with age.
Dendrimer technology gets a grip on cell proteins, could improve cancer treatment
11/12/2015
Purdue researchers have devised a way to capture the finer details of complex cell processes by using tiny synthetic particles known as dendrimers, a technology that could lead to more targeted...
Drug combination for advanced melanoma wins FDA approval
11/12/2015
US regulators have approved a drug combination - vemurafenib (Zelboraf) and cobimetinib (Cotellic) - for advanced melanoma that shows great promise in extending patients' lives.
CCNY researchers open 'Golden Window' in deep brain imaging
11/12/2015
The neuroscience community is saluting the creation of a "Golden Window" for deep brain imaging by researchers at The City College of New York led by biomedical engineer Lingyan Shi.
Previous oral contraceptive use associated with better outcomes in patients with ovarian cancer
11/12/2015
Patients who develop ovarian cancer appear to have better outcomes if they have a history of oral contraceptive use, according to a study by Mayo Clinic researchers published in the current issue of...
Change in a single DNA base drives a childhood cancer
11/12/2015
CHOP researchers detail how a super-enhancer gene causes high-risk neuroblastoma.
Melanoma's genetic trajectories are charted in new study
11/12/2015
Study confirms 'intermediate' disease stage between benign moles and malignancy.
Blood test detects when hormone treatment for breast cancer stops working
11/12/2015
Scientists have developed a highly sensitive blood test that can spot when breast cancers become resistant to standard hormone treatment, and have demonstrated that this test could guide further...
Workers are not being protected from occupational diseases and deaths, argues expert
11/11/2015
British workers are not being protected from occupational diseases and deaths, argues an expert in The BMJ this week.
FDA approves Cotellic as part of combination treatment for advanced melanoma
11/11/2015
The U.S. Food and Drug Administration has approved Cotellic (cobimetinib) to be used in combination with vemurafenib to treat advanced melanoma that has spread to other parts of the body or can't...